Got News to Share? Send 2 FREE Releases ↓
All News Topics | Events By Topic | By Country | By State | By Date

Clinical Development of Orphan Drugs

Submit News
Date: 24-Feb-15 to 25-Feb-15
Location: Park Plaza Victoria London / London / United Kingdom
Category: Healthcare & Pharmaceuticals Conferences & Trade Fairs

A unique opportunity to build new relationships and improve existing partnerships between industry and patient organisations

Clarifying Regulations for Orphan Drugs with case-studies & recommendations to help you overcome common pitfalls in adhering to drug development regulations

Benchmark your orphan drug development programme against leading players such as Pfizer, GSK, Roche & NPS Pharma

Overcome challenges and gain solutions for small populations, critical considerations for trial design & strategies to boost patient enrollment & retention

Improve partnerships with patient organisations with critical recommendations for effective partnering

Get the most from your joint HTA/EMA meeting with critical insight and first-hand advice from NICE

Understand off-label use and its implications for product approval

Arrange one-to-one meetings with key stakeholders via EBD’s partnering system, groupsPLUS

Exhibitors

Martin Andrews, Senior VP Rare Diseases GSK, Leeza Osipenko, Associate Director NICE Scientific Advice, Michael Skynner, Head of External Alliances, Rare Disease Unit, Pfizer, Friedrich Metzger, Head of Discovery Rare Diseases, F.Hoffman-La Roche Ltd, Nicolas Sireau, Chairman and CEO, AKU Society, Bruce Bloom, President and Chief Scientific Officer, Cures Within Reach.

Go to event website